Robin Tuytten speaks at Bravo and Assaymap Bravo Interest Group
Robin Tuytten, Metabolomic Diagnostics VP Research and Development spoke at the recent Bravo and Assaymap Bravo Interest Group meeting September…
Read More
Metabolomic Diagnostics secures additional $2 million in venture funding
Metabolomic Diagnostics, has secured an additional €1.6 million in from investors to help complete PrePsia™, its new screening test for…
Read More
Metabolomic Diagnostics Recruitment
Metabolomic Diagnostics have expanded its team by recruiting Paloma Muñiz Ortea and Leslie Brown. Ms. Muñiz Ortea is our R&D…
Read More
Metabolomic Diagnostics to attend SRI 2016 in Montreal, Canada
Metabolomic Diagnostics’ Director of R&D, Dr. Robin Tuytten will attend the SRI’s 63rd Annual Scientific Meeting, which will take place at…
Read More
Dr. Robin Tuytten’s Webinar on Stratification For Pre-eclampsia
Yesterday afternoon, Metabolomic Diagnostics’ Director of R&D, Dr. Robin Tuytten, hosted a complimentary webinar on Stratification for Pre-eclampsia: Lessons Learned from…
Read More
AACC Complimentary Webinar – Stratification For Pre-eclampsia
On February 29th, join Metabolomic Diagnostics’ Director of R&D, Dr. Robin Tuytten, for an informative look at what it takes…
Read More